<DOC>
	<DOCNO>NCT02383680</DOCNO>
	<brief_summary>Travelers ( n = 30 , 15 take low-dose methotrexate ( MTX ) , 15 healthy control ( HC ) , seek travel advice one follow Swiss Travel Centers ( Aarau , Basel , Bern , Geneva , Lausanne , Zurich ) indication yellow fever ( YF ) vaccination accord Swiss Federal Office Public Health 's vaccination recommendation invite participate study . After sign consent form ( ) YF viremia ( ii ) anti-YF antibody production patient take low-dose MTX HC compare YF vaccination . It analyze whether percentage people protective antibody differs two group ( iii ) vaccine side effect compare group .</brief_summary>
	<brief_title>Yellow Fever Vaccination Under Low Dose Methotrexate Therapy</brief_title>
	<detailed_description>The study conduct form multi-center open-label prospective observational control pilot study . 15 patient low dose methotrexate treatment 15 healthy control indication yellow fever vaccination include . The study duration 28 day subject consist 6 clinical visit day 0 , 3 , 7 , 10 , 14 28 . YF antibody measure day 0 , 7 , 10 , 14 28 ; viremia measure day 3 , 7 , 10 , 14 28 .</detailed_description>
	<mesh_term>Yellow Fever</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Informed Consent document signature Indication yellow fever vaccination accord Swiss FOPH recommendation Individuals low dose MTX ( ≤20mg/week ) therapy healthy individual Male Female traveler ≥18 year &lt; 60 year age Contraindications ethical ground Women pregnant breast feed Contraindication yellow fever vaccination ( e.g . hypersensitivity vaccine ingredient ) Current treatment immunosuppressive agent apart low dose methotrexate Alemtuzumab rituximab last year TNFblocking therapy past three month Immunocompromising condition healthy control Other immunocompromising condition MTX treatment underlie disease patient MTX Previous yellow fever vaccination No indication yellow fever vaccination accord Swiss travel vaccination recommendation Known suspect noncompliance , drug alcohol abuse Inability follow procedure study , e.g . due language problem , psychological disorder , dementia , etc . participant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Methotrexate therapy</keyword>
</DOC>